Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;176(2):291-300.
doi: 10.1111/cei.12279.

Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)

Affiliations

Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)

R M Talaat et al. Clin Exp Immunol. 2014 May.

Abstract

Immune thrombocytopenic purpura (ITP) is acquired autoimmune disease in children characterized by the breakdown of immune tolerance. This work is designed to explore the contribution of different lymphocyte subsets in acute and chronic ITP children. Imbalance in the T helper type 1 (Th1)/Th2 cytokine secretion profile was investigated. The frequency of T (CD3(+), CD4(+), CD8(+)) and B (CD19(+)) lymphocytes, natural killer (NK) (CD16(+) 56(+)) and regulatory T (T(reg)) [CD4(+) CD25(+high) forkhead box protein 3 (FoxP3)(+) ] cells was investigated by flow cytometry in 35 ITP children (15 acute and 20 chronic) and 10 healthy controls. Plasma levels of Th1 cytokines [interferon (IFN-γ) and tumour necrosis factor (TNF-α)] and Th2 [interleukin (IL)-4, IL-6 and IL-10)] cytokines were measured using enzyme-linked immunosorbent assay (ELISA). The percentage of Treg (P < 0·001) and natural killer (NK) (P < 0·001) cells were significantly decreased in ITP patients compared to healthy controls. A negative correlation was reported between the percentage of T(reg) cells and development of acute (r = -0·737; P < 0·01) and chronic (r = -0·515; P < 0·01) disease. All evaluated cytokines (IFN-γ, TNF-α, IL-4, IL-6 and IL-10) were elevated significantly in ITP patients (P < 0·001, P < 0·05, P < 0·05, P < 0·05 and P < 0·001, respectively) compared to controls. In conclusion, our data shed some light on the fundamental role of immune cells and their related cytokines in ITP patients. The loss of tolerance in ITP may contribute to the dysfunction of T(regs). Understanding the role of T cell subsets will permit a better control of autoimmunity through manipulation of their cytokine network.

Keywords: ITP; NK cells; Th1 and Th2 cells; Treg.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow cytometric detection of T lymphocytes, B lymphocytes, natural killer (NK) cells and CD4+CD25+highforkhead box protein 3 (FoxP3)+ regulatory T cells. Forward- and side-scatter histograms were used define the lymphocyte population. A1, A2 and A3: the expression of CD4+and CD8+ was assessed in the total lymphocyte population. B1, B2 and B3: the expression of CD3+ and CD19+ was assessed in total lymphocytes population. C1, C2 and C3: the expression of CD3+ and CD16+56+ was assessed in the total lymphocyte population. D1, D2 and D3: the expression of TCR-γδ was assessed in the total lymphocyte population. E1, E2 and E3: the expression of CD4+ and CD25+ in total lymphocytes was detected and different gates were performed to define CD4+CD25+high cells; F1, F2 and F3 show the percentage of CD4+CD25+highFoxP3.
Figure 2
Figure 2
Plasma levels of T helper type 1 (Th1) [interferon (IFN-γ) and tumour necrosis factor (TNF-α)] and Th2 [interleukin (IL)-4, IL-6 and IL-10] cytokines. Results are expressed as mean ± standard error. (a) Groups statistically significantly different from controls. (b) Groups statistically significantly different from acute immune thrombocytopenia purpura (ITP) patients.*P < 0·05; **P < 0·01; ***P < 0·001.

Similar articles

Cited by

References

    1. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1981;304:1135–1147. - PubMed
    1. Malinowska I, Obitko-Płudowska A, Buescher ES, Wasik M, Rokicka-Milewska R. Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Hematol J. 2001;2:242–249. - PubMed
    1. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–186. - PubMed
    1. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160:1630–1638. - PubMed
    1. Michel M. Immune thrombocytopenic purpura. Epidemiology and implications for patients. Eur J Haematol Suppl. 2009;71:3–7. - PubMed

MeSH terms